Home

Acurx Pharmaceuticals, Inc. - Common Stock (ACXP)

0.4501
-0.0099 (-2.15%)

Acurx Pharmaceuticals Inc is a biopharmaceutical company focused on developing novel antimicrobial therapies to combat bacterial infections, particularly those caused by antibiotic-resistant pathogens

The company is engaged in research and development of innovative drug candidates that address critical unmet medical needs in the treatment of serious infections. With a commitment to advancing therapeutic options, Acurx aims to improve patient outcomes through its proprietary drug formulations and scientific expertise. The company's efforts are geared toward not only treating existing infections but also preventing the spread of multidrug-resistant bacteria in healthcare settings.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close0.4600
Open0.4700
Bid0.4370
Ask0.4539
Day's Range0.4363 - 0.4700
52 Week Range0.4500 - 3.325
Volume323,689
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume445,509

News & Press Releases

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · March 7, 2025
What's going on in today's sessionchartmill.com
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via Chartmill · March 7, 2025
Which stocks are gapping on Friday?chartmill.com
In today's session, there are notable price gaps in the US markets on Friday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · March 7, 2025
Why Acurx Pharmaceuticals (ACXP) Shares Are Down 30%benzinga.com
Acurx Pharmaceuticals shares are trading lower by 30% during Friday's session. The company announced a $1.1 million registered direct offering.
Via Benzinga · March 7, 2025
Earnings Scheduled For November 13, 2024benzinga.com
Via Benzinga · November 13, 2024
New to the Street Announces Exclusive Bloomberg Lineup for October 11 at 6:30 PM EST
Featuring ZAPP, NUBURU, ACURX Pharmaceuticals, The Sustainable Green Team, and SEKUR's Hack of the Week
Via ACCESSWIRE · October 11, 2024
Friday's pre-market session: top gainers and loserschartmill.com
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · March 7, 2025
Dow Dips Over 250 Points; Genesco Shares Plunge After Q4 Resultsbenzinga.com
Via Benzinga · March 7, 2025
Nasdaq Gains 100 Points; US Economy Adds Fewer Jobs Than Projectedbenzinga.com
Via Benzinga · March 7, 2025
New to the Street to Broadcast Show 627 on Bloomberg Television at 6:30 PM EST Today as Sponsored Programming
Featured Segments Include Kevin Harrington on The Sustainable Green Team, Atlas Clear, High Performance Battery, and Modular Medical
Via ACCESS Newswire · February 15, 2025
Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025
STATEN ISLAND, NY / ACCESSWIRE / December 11, 2024 / Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQACXP), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that David P. Luci, President & Chief Executive Officer, will be presenting at The Microcap Conference, which will take place January 28 to January 30, 2025 at the Borgata Hotel, Atlantic City, New Jersey.
Via ACCESSWIRE · December 11, 2024
Bitcoin Hits New All-Time High Above $98,000 As Spot ETFs Crack $100 Billion Net Asset Value Milestonebenzinga.com
As Bitcoin (CRYPTO: BTC) hit a new all-time high of $98,310 on Thursday morning during European trading hours, he total net asset value of U.S. Bitcoin spot exchange-traded funds (ETFs) has exceeded $100 billion, a milestone achieved in just 10 months since their
Via Benzinga · November 21, 2024
New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week"
The episode, airing at 9:30 PM PST, will include insights from The Sustainable Green Team with CEO Tony Raynor and Jimmy Houston.
Via ACCESSWIRE · October 31, 2024
New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)
Also appearing on the show are, Sustainable Green Team (OTCQX:SGTM), Andie Monet with David Fagen, and SEKUR (OTCQX:SWISF)
Via ACCESSWIRE · October 28, 2024
Bloomberg’s “New to The Street” Segment by PetVivo Inc. (OTCQB: PETV) Stocks to Watch This Week inside….
New to The Street, the premier platform for introducing cutting-edge companies, is excited about Bloomberg TV's interviews which aired on Saturday, October 12, 2024 featured key industry leaders , sponsored by PetVivo Holdings Inc. (PETV), including: Zapp Electric Vehicles Group Limited (NASDAQZAPP), NUBURU (NYSEAM: BURU), Acurx Pharmaceuticals, Inc. NASDAQ: ACXPNASDAQACXP)
Via AB Newswire · October 15, 2024
New to the Street Resigns Acurx Pharmaceuticals, Inc. to Multi-Platform Media Series Featuring Broadcast Television, Earned Media, and Outdoor Advertising Support
The new series features continued broadcast television interviews, earned media placements, and a comprehensive outdoor advertising campaign.
Via ACCESSWIRE · October 14, 2024
New to the Street Announces Exclusive Bloomberg Lineup for Saturday October 12 at 6:30 PM EST
Featuring ZAPP, NUBURU, ACURX Pharmaceuticals, The Sustainable Green Team, and SEKUR's Hack of the Week
Via ACCESSWIRE · October 11, 2024
New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ET
Opportunities To Consider™
Via ACCESSWIRE · September 9, 2024
ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q2 2024investorplace.com
ACXP stock results show that Acurx Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 9, 2024
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Via Benzinga · July 18, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · May 21, 2024
ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q1 2024investorplace.com
ACXP stock results show that Acurx Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 15, 2024
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarketbenzinga.com
Shares of Alcoa Corporation (NYSEAA) rose sharply in today’s pre-market trading after the company reported better-than-expected sales for its first quarter.
Via Benzinga · April 18, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · March 19, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · March 19, 2024